• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(18) 食管癌诱导放化疗期间的氟代脱氧葡萄糖摄取无法预测组织形态学肿瘤反应。

(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response.

作者信息

Gillham C M, Lucey J A, Keogan M, Duffy G J, Malik V, Raouf A A, O'byrne K, Hollywood D, Muldoon C, Reynolds J V

机构信息

Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin, Trinity Centre, St James's Hospital, Dublin, Republic of Ireland.

出版信息

Br J Cancer. 2006 Nov 6;95(9):1174-9. doi: 10.1038/sj.bjc.6603412. Epub 2006 Oct 3.

DOI:10.1038/sj.bjc.6603412
PMID:17024121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2360565/
Abstract

To determine whether [(18)F]-fluorodeoxyglucose-positron emission tomography (FDG-PET) could predict the pathological response in oesophageal cancer after only the first week of neoadjuvant chemoradiation. Thirty-two patients with localised oesophageal cancer had a pretreatment PET scan and a repeat after the first week of chemoradiation. The change in mean maximum standardised uptake value (SUV) and volume of metabolically active tissue (MTV) was compared with the tumour regression grade (TRG) in the final histology. Those who achieved a TRG of 1 and 2 were deemed responders and 3-5 nonresponders. In the responders (28%), the SUV fell from 12.6 (+/-6.3) to 8.1 (+/-2.9) after 1 week of chemoradiation (P=0.070). In nonresponders (72%), the results were 9.7 (+/-5.4) and 7.1 (+/-3.8), respectively (P=0.003). The MTV in responders fell from 36.6 (+/-22.7) to 22.3 (+/-10.4) cm(3) (P=0.180), while in nonresponders, this fell from 35.9 (+/-36.7) to 31.9 (+/-52.7) cm(3) (P=0.405). There were no significant differences between responders and nonresponders. The hypothesis that early repeat FDG-PET scanning may predict histomorphologic response was not proven. This may reflect an inflammatory effect of radiation that obscures tumour-specific metabolic changes at this time. This assessment may have limited application in predicting response to multimodal regimens for oesophageal cancer.

摘要

为了确定[18F] - 氟脱氧葡萄糖 - 正电子发射断层扫描(FDG - PET)是否仅在新辅助放化疗第一周后就能预测食管癌的病理反应。32例局限性食管癌患者在新辅助放化疗前进行了PET扫描,并在放化疗第一周后进行了复查。将平均最大标准化摄取值(SUV)和代谢活跃组织体积(MTV)的变化与最终组织学检查中的肿瘤退缩分级(TRG)进行比较。TRG为1和2的患者被视为反应者,3 - 5级为无反应者。在反应者(28%)中,放化疗1周后SUV从12.6(±6.3)降至8.1(±2.9)(P = 0.070)。在无反应者(72%)中,结果分别为9.7(±5.4)和7.1(±3.8)(P = 0.003)。反应者的MTV从36.6(±22.7)降至22.3(±10.4)cm³(P = 0.180),而在无反应者中,MTV从35.9(±36.7)降至31.9(±52.7)cm³(P = 0.405)。反应者和无反应者之间无显著差异。早期重复FDG - PET扫描可预测组织形态学反应这一假设未得到证实。这可能反映了放疗的炎症效应,此时掩盖了肿瘤特异性代谢变化。这种评估在预测食管癌多模式治疗方案的反应方面应用可能有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/2360565/f2ee2d8f4fc7/95-6603412f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/2360565/9e3a322d8cb7/95-6603412f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/2360565/f2ee2d8f4fc7/95-6603412f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/2360565/9e3a322d8cb7/95-6603412f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/2360565/f2ee2d8f4fc7/95-6603412f2.jpg

相似文献

1
(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response.(18) 食管癌诱导放化疗期间的氟代脱氧葡萄糖摄取无法预测组织形态学肿瘤反应。
Br J Cancer. 2006 Nov 6;95(9):1174-9. doi: 10.1038/sj.bjc.6603412. Epub 2006 Oct 3.
2
To determine the utility of fluorodeoxyglucose-positron emission tomography-computed tomography scan in predicting pathological response in operated carcinoma rectum patients after initial neoadjuvant chemoradiation.为确定氟脱氧葡萄糖-正电子发射断层扫描-计算机断层扫描在预测接受初始新辅助放化疗的直肠癌手术患者的病理反应中的效用。
J Cancer Res Ther. 2019 Jan-Mar;15(1):9-14. doi: 10.4103/jcrt.JCRT_873_17.
3
To Compare and Determine the Diagnostic Accuracy of [F]-fluorodeoxyglucose Positron Emission Tomography Scan in Predicting Pathological Response in Operated Carcinoma Esophagus Patients after Initial Neoadjuvant Chemoradiation and Neoadjuvant Chemotherapy.比较并确定[F]-氟脱氧葡萄糖正电子发射断层扫描在预测接受初始新辅助放化疗和新辅助化疗后的食管癌手术患者病理反应中的诊断准确性。
World J Nucl Med. 2018 Apr-Jun;17(2):79-85. doi: 10.4103/wjnm.WJNM_23_17.
4
Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.肿瘤内18F-FDG摄取异质性降低了正电子发射断层扫描/计算机断层扫描成像在靶体积定义上的可靠性。
J Med Imaging Radiat Oncol. 2015 Jun;59(3):338-45. doi: 10.1111/1754-9485.12289. Epub 2015 Feb 23.
5
The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.18F-FDG PET/CT 序列检查在预测直肠癌术前放化疗后肿瘤反应中的作用。
Colorectal Dis. 2013 May;15(5):e231-8. doi: 10.1111/codi.12165.
6
[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer.18F-氟代脱氧葡萄糖正电子发射断层扫描用于评估新辅助放化疗后食管癌的组织病理学反应和预后。
Ann Surg. 2009 Dec;250(6):888-94. doi: 10.1097/sla.0b013e3181bc9c0d.
7
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.重复 PET/CT 的代谢反应可预测食管癌新辅助化疗的病理反应。
Eur Radiol. 2012 Sep;22(9):2035-43. doi: 10.1007/s00330-012-2459-5. Epub 2012 May 5.
8
Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy.用于评估食管鳞状细胞癌或腺癌放化疗后组织病理学反应的[18F]FDG-PET中的平均和最大标准化摄取值。
Eur J Nucl Med Mol Imaging. 2009 May;36(5):735-44. doi: 10.1007/s00259-008-1011-y. Epub 2008 Dec 19.
9
Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus.新辅助放化疗期间多次重复 18F-FDG PET 扫描无法预测食管腺癌的病理反应或生存获益。
J Nucl Med. 2010 Dec;51(12):1863-9. doi: 10.2967/jnumed.110.079566. Epub 2010 Nov 15.
10
Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.使用[18F]氟脱氧葡萄糖正电子发射断层扫描进行连续成像和组织病理学评估,以预测新辅助治疗后可手术切除的远端食管癌和胃腺癌患者的生存率。
Ann Nucl Med. 2017 May;31(4):315-323. doi: 10.1007/s12149-017-1159-2. Epub 2017 Mar 15.

引用本文的文献

1
Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review.新辅助放化疗后食管癌病理和临床反应的肿瘤微环境潜在预测免疫和代谢生物标志物:系统评价。
Ann Surg Oncol. 2024 Jan;31(1):433-451. doi: 10.1245/s10434-023-14352-z. Epub 2023 Sep 30.
2
Interim position emission tomography-computed tomography during multimodality treatment of locally advanced esophageal cancer: a scoping review.局部晚期食管癌多模态治疗期间的中期正电子发射断层扫描-计算机断层扫描:一项范围综述
Quant Imaging Med Surg. 2023 Sep 1;13(9):6280-6295. doi: 10.21037/qims-22-1306. Epub 2023 Jul 17.
3

本文引用的文献

1
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.单纯手术与放化疗后手术治疗可切除食管癌的对比:一项随机对照III期试验
Lancet Oncol. 2005 Sep;6(9):659-68. doi: 10.1016/S1470-2045(05)70288-6.
2
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).提议修订食管癌分期系统,以适应术前放化疗(CRT)后的病理反应(pP)。
Ann Surg. 2005 May;241(5):810-7; discussion 817-20. doi: 10.1097/01.sla.0000161983.82345.85.
3
Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.
Dynamic Characteristics and Predictive Capability of Tumor Voxel Dose-Response Assessed Using F-FDG PET/CT Imaging Feedback.
使用F-FDG PET/CT成像反馈评估肿瘤体素剂量反应的动态特征和预测能力。
Front Oncol. 2022 Jul 6;12:876861. doi: 10.3389/fonc.2022.876861. eCollection 2022.
4
FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study.FDG-PET-CT 识别局部晚期胃癌和贲门癌新辅助化疗后的组织病理学无应答者:队列研究。
BMC Cancer. 2018 May 9;18(1):548. doi: 10.1186/s12885-018-4477-4.
5
To Compare and Determine the Diagnostic Accuracy of [F]-fluorodeoxyglucose Positron Emission Tomography Scan in Predicting Pathological Response in Operated Carcinoma Esophagus Patients after Initial Neoadjuvant Chemoradiation and Neoadjuvant Chemotherapy.比较并确定[F]-氟脱氧葡萄糖正电子发射断层扫描在预测接受初始新辅助放化疗和新辅助化疗后的食管癌手术患者病理反应中的诊断准确性。
World J Nucl Med. 2018 Apr-Jun;17(2):79-85. doi: 10.4103/wjnm.WJNM_23_17.
6
F-18-FDG and C-11-Choline Positron Emission Tomography in Human Esophago-Gastric Cancer: Prediction of Response to Therapy.F-18-氟代脱氧葡萄糖和C-11-胆碱正电子发射断层扫描在人食管癌和胃癌中的应用:对治疗反应的预测
World J Oncol. 2010 Apr;1(2):66-67. doi: 10.4021/wjon2010.04.201w. Epub 2010 Apr 30.
7
Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma.胃和胃食管结合部腺癌患者治疗后/术前 PET 反应不是结局的独立预测因素。
Ann Surg. 2018 May;267(5):898-904. doi: 10.1097/SLA.0000000000002306.
8
The role of PET and PET-CT scanning in assessing response to neoadjuvant therapy in esophageal carcinoma.正电子发射断层扫描(PET)及PET计算机断层扫描(PET-CT)在评估食管癌新辅助治疗反应中的作用。
Dtsch Arztebl Int. 2015 Aug 17;112(33-34):545-52. doi: 10.3238/arztebl.2015.0545.
9
Neoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatment.晚期食管癌的新辅助治疗:术前反应评估以及在开始治疗前如何预测对放化疗的反应。
Chin J Cancer Res. 2015 Jun;27(3):221-30. doi: 10.3978/j.issn.1000-9604.2015.04.04.
10
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.食管癌新辅助放化疗后残留疾病检测的准确性(preSANO试验):原理与方案
JMIR Res Protoc. 2015 Jun 29;4(2):e79. doi: 10.2196/resprot.4320.
基于SUV的不同方法在利用FDG PET监测细胞毒性治疗中的比较。
Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1471-8. doi: 10.1007/s00259-004-1626-6. Epub 2004 Jul 15.
4
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.食管癌术前放化疗:一项系统评价与荟萃分析
Gut. 2004 Jul;53(7):925-30. doi: 10.1136/gut.2003.025080.
5
Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma.新辅助放化疗对食管癌18F-FDG-PET的影响。
Eur J Surg Oncol. 2004 Jun;30(5):544-50. doi: 10.1016/j.ejso.2004.03.007.
6
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.食管鳞状细胞癌放化疗期间肿瘤代谢活性的时间进程及对治疗的反应
J Clin Oncol. 2004 Mar 1;22(5):900-8. doi: 10.1200/JCO.2004.07.122.
7
Esophageal cancer.食管癌
N Engl J Med. 2003 Dec 4;349(23):2241-52. doi: 10.1056/NEJMra035010.
8
Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography in patients with esophageal cancer.采用正电子发射断层扫描定量分析2-脱氧-2-[18F]氟-D-葡萄糖评估食管癌患者新辅助治疗的反应
Mol Imaging Biol. 2002 Jul;4(4):301-10. doi: 10.1016/s1536-1632(02)00011-2.
9
Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach?正电子发射断层扫描用于食管癌分期:它会导致不同的治疗方法吗?
World J Surg. 2003 Oct;27(10):1105-12. doi: 10.1007/s00268-003-6921-z. Epub 2003 Aug 18.
10
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.正电子发射断层扫描与计算机断层扫描相结合用于非小细胞肺癌分期
N Engl J Med. 2003 Jun 19;348(25):2500-7. doi: 10.1056/NEJMoa022136.